COVID-19 Vaccine ‘Possibly’ Linked to Rare Blood Clots: EU Agency

The European Union’s drug regulation agency on Wednesday said there is a “possible link” between the AstraZeneca CCP virus vaccine and “very rare” blood clots but recommended that vaccinations continue and stressed the benefits outweigh the risks. The European Medicines Agency (EMA) “is reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination,” the agency said in a statement Wednesday. The statement continued: “So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed.” The Epoch Times has contacted AstraZeneca for comment. The pharmaceutical giant and the World Health Organization (WHO) have previously stated that its studies have found no higher risk of clots …
Read More
UK news | The Epoch Times